Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1151 of 5804
-
New combo aims to shield rheumatoid arthritis patients from heart attacks
Disease control Recruiting nowThe rationale of our study is to observe the incidence of MACE in RA patients treated with tofacitinib along with statins with one or more cardiovascular disease risks. PRIMARY OBJECTIVE * To determine the incidence of MACE in Rheumatoid Arthritis patients with moderate to high…
Phase: PHASE4 • Sponsor: Shaikh Zayed Hospital, Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New Mini-Open spine surgery aims to cut recovery time for spinal stenosis patients
Symptom relief Not yet recruitingThis clinical study aims to find out if a modified mini-open spine surgery (modified mini-open transforaminal lumbar interbody fusion,mMO-TLIF) is as good as, or better than, the traditional open surgery (traditional transforaminal lumbar interbody fusion,traditional TLIF) for tr…
Phase: NA • Sponsor: The First People's Hospital of Lianyungang • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can acupuncture and magnetic pulses restore arm function after a stroke?
Disease control Not yet recruitingThis study aims to compare the improvement effects of the rTMS (repetitive transcranial magnetic stimulation) combined with conventional rehabilitation therapy group with the rTMS combined with scalp acupuncture and conventional rehabilitation therapy group. Through statistical a…
Phase: NA • Sponsor: Debiao Kong • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New heart ablation method could be safer, trial aims to prove
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether pulsed field ablation (PFA) using the novel VOLT catheter is as safe and effective as conventional thermal ablation (radiofrequency or cryotherapy) for the treatment of atrial fibrillation (AF) in adult patients undergoing th…
Phase: NA • Sponsor: Sebastien Knecht • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New daily pill could tame bone sarcomas
Disease control Recruiting nowTo study the treatment efficacy of zanzalintinib monotherapy in patients with advanced and/or metastatic bone sarcomas.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for thyroid eye disease: phase 3 drug trial launches in china
Disease control Recruiting nowA Multicenter, Double-blinded, Randomized, Placebo-controlled Phase 3 Study of ZL-1109 in Chinese Participants with Thyroid Eye Disease (TED)
Phase: PHASE3 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New shot shows promise against tough cancers
Disease control Recruiting nowThis study aims to find the right dosage and evaluate the safety and effectiveness of the drug IPN60300 in adults with advanced solid tumours, which are cancers that have spread to other parts of the body from their original location. All participants will receive the drug by inj…
Phase: PHASE1, PHASE2 • Sponsor: Ipsen • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New combo pill aims to protect kidneys in High-Risk patients
Disease control Recruiting nowInternational, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New COVID booster vaccine tested as nasal spray and shot
⭐️ VACCINE ⭐️ OngoingThis phase 1 clinical trial will evaluate the safety, reactogenicity, and immunogenicity of Boost-2867, given intramuscular (IM) with or without adjuvant or intranasal (IN) without adjuvant, as a booster dose to previously vaccinated healthy adults. Each of the study sites will b…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
One pill to rule them all? new study tests polypill for heart attack patients
Disease control Recruiting nowThe current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improve outcomes following an ACS event. Although these therapies are effective, gaps …
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a pill and gel combo restore skin color in vitiligo?
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of SHR0302 tablets as single therapy or in combination with SHR0302 Base gel for patients with non-segmental vitiligo.
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for Hard-to-Treat breast cancer: experimental drug CLR 125 enters human testing
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of 3 different dose levels of CLR 125 in patients with advanced triple negative breast cancer. The main questions the study aims to answer are: * What dose and regimen should be used in future trials of CLR 1…
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for PNH patients: LP-005 shows promise in long-term trial
Disease control Not yet recruitingThis is an extension study for patients who have completed a prior P10-LP005-02 clinical study. The aim of this study is to evaluate the long-term safety, efficacy, and pharmacokinetics of LP-005 injection in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Cold water trick may stop pancreatitis after common procedure
Prevention Recruiting nowThis study is designed to learn whether rinsing the papilla with cold water at the end of an ERCP procedure, in addition to standard medicine, can help lower the chance of developing pancreatitis, which is the most common major complication after ERCP.
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Collagen wrap may help hands heal better after tendon surgery
Disease control CompletedTendon injuries of the hand, particularly extensor tendons, are prone to postoperative adhesions, extensor lag, and stiffness, leading to functional impairment. This multicentric randomized controlled trial evaluates whether wrapping repaired extensor tendons with a high-purity T…
Phase: NA • Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New eye drop takes on pesky eyelash mites
Disease control Recruiting nowThis is a randomized, double-masked, placebo-controlled, dose-ranging, parallel-group, multi-center study designed to evaluate the safety and efficacy of GLK-321 in patients with Demodex blepharitis.
Phase: PHASE2 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New mastectomy technique aims to reduce wound complications and improve appearance
Symptom relief Recruiting nowThis randomized, open-label study compares endoscopic skin-sparing mastectomy (E-SSM) with conventional mastectomy (CM) in female patients with unilateral invasive breast cancer (T1-4aN0-3M0). The primary objective is to evaluate differences in postoperative wound complications a…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for tough arthritis cases: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Virtual reality could replace pills for Kids' casting pain
Symptom relief Recruiting nowThis prospective randomized controlled trial will evaluate whether virtual reality can reduce procedural distress in children undergoing cast application for forearm fractures. Children will be assigned to either a virtual reality group or a standard care group. In the virtual re…
Phase: NA • Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New drug offers hope for breast cancer patients suffering from hot flashes
Symptom relief Recruiting nowThis is a phase II, randomized, double-blinded, placebo-controlled trial designed to evaluate the efficacy of fezolinetant (45 mg a day) vs. placebo in reducing moderate to severe vasomotor symptoms (VMS) in breast cancer survivors on endocrine therapy (tamoxifen, aromatase inhib…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC